Home » Topics » Science » New compound

New compound
RSS

Calpain inhibitor BLD-2736 is protective against spinocerebellar ataxia type 3

Oct. 20, 2021

BGS-1989: a promising compound for treating WDR5-dependent cancers

Oct. 19, 2021

IEM presents new antiparkinsonian compounds

Oct. 18, 2021

CT-7439: a potential first-in-class oral cyclin K glue degrader

Oct. 15, 2021

ENPP1 inhibitor TXN-10128 shows promising antitumor activity trough restoration of STING activation

Oct. 13, 2021

SG-3-00802 shows encouraging preclinical activity in combination with anti-PD-1 therapy

Oct. 8, 2021

Preclinical assessment of the novel GLP-1 receptor agonist GZR-18

Oct. 6, 2021

JSF-3151 demonstrates efficacy in mouse model of MRSA infection

Oct. 5, 2021

GlaxoSmithKline details discovery of new class of BET BD2 inhibitors

Oct. 4, 2021

ER-001259851-000, novel selective Axl inhibitor with promising PK profile in vivo

Sep. 30, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 29, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...